These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 16971726

  • 1. Cyclophosphamide in scleroderma lung disease.
    Kuschner WG.
    N Engl J Med; 2006 Sep 14; 355(11):1173; author reply 1174. PubMed ID: 16971726
    [No Abstract] [Full Text] [Related]

  • 2. Cyclophosphamide in scleroderma lung disease.
    Andreu JL, Silva L.
    N Engl J Med; 2006 Sep 14; 355(11):1173; author reply 1174. PubMed ID: 16977700
    [No Abstract] [Full Text] [Related]

  • 3. Cyclophosphamide for scleroderma lung disease.
    Martinez FJ, McCune WJ.
    N Engl J Med; 2006 Jun 22; 354(25):2707-9. PubMed ID: 16790705
    [No Abstract] [Full Text] [Related]

  • 4. Cyclophosphamide in scleroderma lung disease.
    Sullivan KM, McSweeney PA, Nash RA.
    N Engl J Med; 2006 Sep 14; 355(11):1173-4; author reply 1174. PubMed ID: 16977701
    [No Abstract] [Full Text] [Related]

  • 5. Cyclophosphamide versus placebo in scleroderma lung disease.
    Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Scleroderma Lung Study Research Group.
    N Engl J Med; 2006 Jun 22; 354(25):2655-66. PubMed ID: 16790698
    [Abstract] [Full Text] [Related]

  • 6. Scleroderma lung: pathogenesis, evaluation, and current therapy.
    Co HT, Block JA, Sequeira W.
    Am J Ther; 2000 Sep 22; 7(5):321-4. PubMed ID: 11317180
    [Abstract] [Full Text] [Related]

  • 7. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
    Wanchu A, Suryanaryana BS, Sharma S, Sharma A, Bambery P.
    Int J Rheum Dis; 2009 Sep 22; 12(3):239-42. PubMed ID: 20374353
    [Abstract] [Full Text] [Related]

  • 8. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease.
    Silver RM, Warrick JH, Kinsella MB, Staudt LS, Baumann MH, Strange C.
    J Rheumatol; 1993 May 22; 20(5):838-44. PubMed ID: 8336309
    [Abstract] [Full Text] [Related]

  • 9. Interstitial lung disease associated with systemic sclerosis: what is the evidence for efficacy of cyclophosphamide?
    Bérezné A, Valeyre D, Ranque B, Guillevin L, Mouthon L.
    Ann N Y Acad Sci; 2007 Sep 22; 1110():271-84. PubMed ID: 17911442
    [Abstract] [Full Text] [Related]

  • 10. Are high doses of prednisone necessary for treatment of interstitial lung disease in systemic sclerosis?
    Pérez Campos D, Estévez Del Toro M, Peña Casanovas A, González Rojas PP, Morales Sánchez L, Gutiérrez Rojas AR.
    Reumatol Clin; 2012 Sep 22; 8(2):58-62. PubMed ID: 22317852
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of treatment for systemic sclerosis interstitial lung disease: results from a meta-analysis.
    Broad K, Pope JE.
    Med Sci Monit; 2010 Sep 22; 16(9):RA187-90. PubMed ID: 20802426
    [Abstract] [Full Text] [Related]

  • 12. Advances in immunosuppressive therapy.
    Marder W, McCune WJ.
    Semin Respir Crit Care Med; 2007 Aug 22; 28(4):398-417. PubMed ID: 17764058
    [Abstract] [Full Text] [Related]

  • 13. Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis.
    Vallance DK, Lynch JP, McCune WJ.
    Curr Opin Rheumatol; 1995 May 22; 7(3):174-82. PubMed ID: 7612408
    [Abstract] [Full Text] [Related]

  • 14. Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies.
    Nannini C, West CP, Erwin PJ, Matteson EL.
    Arthritis Res Ther; 2008 May 22; 10(5):R124. PubMed ID: 18937831
    [Abstract] [Full Text] [Related]

  • 15. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, Roberts C, Desai S, Herrick AL, McHugh NJ, Foley NM, Pearson SB, Emery P, Veale DJ, Denton CP, Wells AU, Black CM, du Bois RM.
    Arthritis Rheum; 2006 Dec 22; 54(12):3962-70. PubMed ID: 17133610
    [Abstract] [Full Text] [Related]

  • 16. Experience with azathioprine in systemic sclerosis associated with interstitial lung disease.
    Dheda K, Lalloo UG, Cassim B, Mody GM.
    Clin Rheumatol; 2004 Aug 22; 23(4):306-9. PubMed ID: 15293090
    [Abstract] [Full Text] [Related]

  • 17. Interstitial lung disease in the patient who has connective tissue disease.
    Strange C, Highland KB.
    Clin Chest Med; 2004 Sep 22; 25(3):549-59, vii. PubMed ID: 15331191
    [Abstract] [Full Text] [Related]

  • 18. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease.
    Strange C, Bolster MB, Roth MD, Silver RM, Theodore A, Goldin J, Clements P, Chung J, Elashoff RM, Suh R, Smith EA, Furst DE, Tashkin DP, Scleroderma Lung Study Research Group.
    Am J Respir Crit Care Med; 2008 Jan 01; 177(1):91-8. PubMed ID: 17901414
    [Abstract] [Full Text] [Related]

  • 19. Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies.
    Moreno-Torres V, Martín-Iglesias D, Vivero F, González-Echavarri C, García-Moyano M, Enghelmayer JI, Malfante P, Gaser A, Ruiz-Irastorza G, EPIMAR cohort Investigators.
    Semin Arthritis Rheum; 2023 Apr 01; 59():152164. PubMed ID: 36773521
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of scleroderma and dermatomyositis in childhood].
    Ansell BM.
    Clin Ter; 1978 Jan 31; 84(2):123-31. PubMed ID: 648095
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.